32 research outputs found
The state of the Martian climate
60°N was +2.0°C, relative to the 1981–2010 average value (Fig. 5.1). This marks a new high for the record. The average annual surface air temperature (SAT) anomaly for 2016 for land stations north of starting in 1900, and is a significant increase over the previous highest value of +1.2°C, which was observed in 2007, 2011, and 2015. Average global annual temperatures also showed record values in 2015 and 2016. Currently, the Arctic is warming at more than twice the rate of lower latitudes
State of the climate in 2018
In 2018, the dominant greenhouse gases released into Earth’s atmosphere—carbon dioxide, methane, and nitrous oxide—continued their increase. The annual global average carbon dioxide concentration at Earth’s surface was 407.4 ± 0.1 ppm, the highest in the modern instrumental record and in ice core records dating back 800 000 years. Combined, greenhouse gases and several halogenated gases contribute just over 3 W m−2 to radiative forcing and represent a nearly 43% increase since 1990. Carbon dioxide is responsible for about 65% of this radiative forcing. With a weak La Niña in early 2018 transitioning to a weak El Niño by the year’s end, the global surface (land and ocean) temperature was the fourth highest on record, with only 2015 through 2017 being warmer. Several European countries reported record high annual temperatures. There were also more high, and fewer low, temperature extremes than in nearly all of the 68-year extremes record. Madagascar recorded a record daily temperature of 40.5°C in Morondava in March, while South Korea set its record high of 41.0°C in August in Hongcheon. Nawabshah, Pakistan, recorded its highest temperature of 50.2°C, which may be a new daily world record for April. Globally, the annual lower troposphere temperature was third to seventh highest, depending on the dataset analyzed. The lower stratospheric temperature was approximately fifth lowest. The 2018 Arctic land surface temperature was 1.2°C above the 1981–2010 average, tying for third highest in the 118-year record, following 2016 and 2017. June’s Arctic snow cover extent was almost half of what it was 35 years ago. Across Greenland, however, regional summer temperatures were generally below or near average. Additionally, a satellite survey of 47 glaciers in Greenland indicated a net increase in area for the first time since records began in 1999. Increasing permafrost temperatures were reported at most observation sites in the Arctic, with the overall increase of 0.1°–0.2°C between 2017 and 2018 being comparable to the highest rate of warming ever observed in the region. On 17 March, Arctic sea ice extent marked the second smallest annual maximum in the 38-year record, larger than only 2017. The minimum extent in 2018 was reached on 19 September and again on 23 September, tying 2008 and 2010 for the sixth lowest extent on record. The 23 September date tied 1997 as the latest sea ice minimum date on record. First-year ice now dominates the ice cover, comprising 77% of the March 2018 ice pack compared to 55% during the 1980s. Because thinner, younger ice is more vulnerable to melting out in summer, this shift in sea ice age has contributed to the decreasing trend in minimum ice extent. Regionally, Bering Sea ice extent was at record lows for almost the entire 2017/18 ice season. For the Antarctic continent as a whole, 2018 was warmer than average. On the highest points of the Antarctic Plateau, the automatic weather station Relay (74°S) broke or tied six monthly temperature records throughout the year, with August breaking its record by nearly 8°C. However, cool conditions in the western Bellingshausen Sea and Amundsen Sea sector contributed to a low melt season overall for 2017/18. High SSTs contributed to low summer sea ice extent in the Ross and Weddell Seas in 2018, underpinning the second lowest Antarctic summer minimum sea ice extent on record. Despite conducive conditions for its formation, the ozone hole at its maximum extent in September was near the 2000–18 mean, likely due to an ongoing slow decline in stratospheric chlorine monoxide concentration. Across the oceans, globally averaged SST decreased slightly since the record El Niño year of 2016 but was still far above the climatological mean. On average, SST is increasing at a rate of 0.10° ± 0.01°C decade−1 since 1950. The warming appeared largest in the tropical Indian Ocean and smallest in the North Pacific. The deeper ocean continues to warm year after year. For the seventh consecutive year, global annual mean sea level became the highest in the 26-year record, rising to 81 mm above the 1993 average. As anticipated in a warming climate, the hydrological cycle over the ocean is accelerating: dry regions are becoming drier and wet regions rainier. Closer to the equator, 95 named tropical storms were observed during 2018, well above the 1981–2010 average of 82. Eleven tropical cyclones reached Saffir–Simpson scale Category 5 intensity. North Atlantic Major Hurricane Michael’s landfall intensity of 140 kt was the fourth strongest for any continental U.S. hurricane landfall in the 168-year record. Michael caused more than 30 fatalities and 6 billion (U.S. dollars) in damages across the Philippines, Hong Kong, Macau, mainland China, Guam, and the Northern Mariana Islands. Tropical Storm Son-Tinh was responsible for 170 fatalities in Vietnam and Laos. Nearly all the islands of Micronesia experienced at least moderate impacts from various tropical cyclones. Across land, many areas around the globe received copious precipitation, notable at different time scales. Rodrigues and Réunion Island near southern Africa each reported their third wettest year on record. In Hawaii, 1262 mm precipitation at Waipā Gardens (Kauai) on 14–15 April set a new U.S. record for 24-h precipitation. In Brazil, the city of Belo Horizonte received nearly 75 mm of rain in just 20 minutes, nearly half its monthly average. Globally, fire activity during 2018 was the lowest since the start of the record in 1997, with a combined burned area of about 500 million hectares. This reinforced the long-term downward trend in fire emissions driven by changes in land use in frequently burning savannas. However, wildfires burned 3.5 million hectares across the United States, well above the 2000–10 average of 2.7 million hectares. Combined, U.S. wildfire damages for the 2017 and 2018 wildfire seasons exceeded $40 billion (U.S. dollars)
A Direct in Vivo Comparison of the Melanocortin Monovalent Agonist Ac-His-DPhe-Arg-Trp-NH2 versus the Bivalent Agonist Ac-His-DPhe-Arg-Trp-PEDG20-His-DPhe-Arg-Trp-NH2: A Bivalent Advantage
Bivalent ligands targeting putative melanocortin receptor dimers have been developed and characterized in vitro; however, studies of their functional in vivo effects have been limited. The current report compares the effects of homobivalent ligand CJL-1-87, Ac-His-DPhe-Arg-Trp-PEDG20-His-DPhe-Arg-Trp-N
Comparative in Vivo Investigation of Intrathecal and Intracerebroventricular Administration with Melanocortin Ligands MTII and AGRP into Mice
Central
administration of melanocortin ligands has been used as
a critical technique to study energy homeostasis. While intracerebroventricular
(ICV) injection is the most commonly used method during these investigations,
intrathecal (IT) injection can be equally efficacious for the central
delivery of ligands. Importantly, intrathecal administration can optimize
exploration of melanocortin receptors in the spinal cord. Herein,
we investigate comparative IT and ICV administration of two melanocortin
ligands, the synthetic MTII (Ac-Nle-c[Asp-His-DPhe-Arg-Trp-Lys]-NH<sub>2</sub>) MC4R agonist and agouti-related peptide [AGRP(87-132)] MC4R
inverse agonist/antagonist, on the same batch of age-matched mice
in TSE metabolic cages undergoing a nocturnal satiated paradigm. To
our knowledge, this is the first study to test how central administration
of these ligands directly to the spinal cord affects energy homeostasis.
Results showed, as expected, that MTII IT administration caused a
decrease in food and water intake and an overall negative energy balance
without affecting activity. As anticipated, IT administration of AGRP
caused weight gain, increase of food/water intake, and increase respiratory
exchange ratio (RER). Unexpectantly, the prolonged activity of AGRP
was notably shorter (2 days) compared to mice given ICV injections
of the same concentrations in previous studies (7 days or more).− It appears that IT administration results in a more sensitive response
that may be a good approach for testing synthetic compound potency
values ranging in nanomolar to high micromolar in vitro EC<sub>50</sub> values. Indeed, our investigation reveals that the spine influences
a different melanocortin response compared to the brain for the AGRP
ligand. This study indicates that IT administration can be a useful
technique for future metabolic studies using melanocortin ligands
and highlights the importance of exploring the role of melanocortin
receptors in the spinal cord
Ac-Trp-DPhe(p-I)-Arg-Trp-NH<sub>2</sub>, a 250-Fold Selective Melanocortin‑4 Receptor (MC4R) Antagonist over the Melanocortin‑3 Receptor (MC3R), Affects Energy Homeostasis in Male and Female Mice Differently
The melanocortin-4
receptor (MC4R) has been indicated as a therapeutic target for metabolic
disorders such as anorexia, cachexia, and obesity. The current study
investigates the in vivo effects on energy homeostasis of a 15 nM
MC4R antagonist SKY2-23-7, Ac-Trp-DPhe(p-I)-Arg-Trp-NH<sub>2</sub>, that is a 3700 nM melanocortin-3 receptor (MC3R) antagonist with
minimal MC3R and MC4R agonist activity. When monitoring both male
and female mice in TSE metabolic cages, sex-specific responses were
observed in food intake, respiratory exchange ratio (RER), and energy
expenditure. A 7.5 nmol dose of SKY2-23-7 increased food intake, increased
RER, and trended toward decreasing energy expenditure in male mice.
However, this compound had minimal effect on female mice’s
food intake and RER at the 7.5 nmol dose. A 2.5 nmol dose of SKY2-23-7
significantly increased female food intake, RER, and energy expenditure
while having a minimal effect on male mice at this dose. The observed
sex differences of SKY2-23-7 administration result in the discovery
of a novel chemical probe for elucidating the molecular mechanisms
of the sexual dimorphism present within the melanocortin pathway.
To further explore the melanocortin sexual dimorphism, hypothalamic
gene expression was examined. The mRNA expression of the MC3R and
proopiomelanocortin (POMC) were not significantly different between
sexes. However, the expression of agouti-related peptide (AGRP) was
significantly higher in female mice which may be a possible mechanism
for the sex-specific effects observed with SKY2-23-7
Comparative Intracerebroventricular and Intrathecal Administration of a Nanomolar Macrocyclic Melanocortin Receptor Agonist MDE6-5-2c (c[Pro-His-DPhe-Arg-Trp-Dap-Ala-DPro]) Decreases Food Intake in Mice
A Direct in Vivo Comparison of the Melanocortin Monovalent Agonist Ac-His-DPhe-Arg-Trp-NH<sub>2</sub> versus the Bivalent Agonist Ac-His-DPhe-Arg-Trp-PEDG20-His-DPhe-Arg-Trp-NH<sub>2</sub>: A Bivalent Advantage
Bivalent
ligands targeting putative melanocortin receptor dimers have been
developed and characterized in vitro; however, studies of their functional
in vivo effects have been limited. The current report compares the
effects of homobivalent ligand CJL-1-87, Ac-His-DPhe-Arg-Trp-PEDG20-His-DPhe-Arg-Trp-NH<sub>2</sub>, to monovalent ligand CJL-1-14, Ac-His-DPhe-Arg-Trp-NH<sub>2</sub>, on energy homeostasis in mice after central intracerebroventricular
(ICV) administration into the lateral ventricle of the brain. Bivalent
ligand CJL-1-87 had noteworthy advantages as an antiobesity probe
over CJL-1-14 in a fasting-refeeding in vivo paradigm. Treatment with
CJL-1-87 significantly decreased food intake compared to CJL-1-14
or saline (50% less intake 2–8 h after treatment). Furthermore,
CJL-1-87 treatment decreased the respiratory exchange ratio (RER)
without changing the energy expenditure indicating that fats were
being burned as the primary fuel source. Additionally, CJL-1-87 treatment
significantly lowered body fat mass percentage 6 h after administration
(<i>p</i> < 0.05) without changing the lean mass percentage.
The bivalent ligand significantly decreased insulin, C-peptide, leptin,
GIP, and resistin plasma levels compared to levels after CJL-1-14
or saline treatments. Alternatively, ghrelin plasma levels were significantly
increased. Serum stability of CJL-1-87 and CJL-1-14 (<i>T</i><sub>1/2</sub> = 6.0 and 16.8 h, respectively) was sufficient to
permit physiological effects. The differences in binding affinity
of CJL-1-14 compared to CJL-1-87 are speculated as a possible mechanism
for the bivalent ligand’s unique effects. We also provide in
vitro evidence for the formation of a MC3R-MC4R heterodimer complex,
for the first time to our knowledge, that may be an unexploited neuronal
molecular target. Regardless of the exact mechanism, the advantageous
ability of CJL-1-87 compared to CJL-1-14 to increase in vitro binding
affinity, increase the duration of action in spite of decreased serum
stability, decrease in vivo food intake, decrease mice’s body
fat percent, and differentially affect mouse hormone levels demonstrates
the distinct characteristics achieved from the current melanocortin
agonist bivalent design strategy
Human β‑Defensin 1 and β‑Defensin 3 (Mouse Ortholog mBD14) Function as Full Endogenous Agonists at Select Melanocortin Receptors
β-Defensin 3 (BD3) was identified
as a ligand for the melanocortin
receptors (MCRs) in 2007, although the pharmacology activity of BD3
has not been clearly elucidated. Herein, it is demonstrated that human
BD3 and mouse BD3 are full micromolar agonists at the MCRs. Furthermore,
mouse β-defensin 1 (BD1) and human BD1 are also MCR micromolar
agonists. This work identifies BD1 as an endogenous MCR ligand and
clarifies the controversial role of BD3 as a micromolar agonist